Evaluation of cathepsin D as a prognostic factor in breast cancer
- 1 October 1993
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 24 (3) , 219-226
- https://doi.org/10.1007/bf01833262
Abstract
The biologic rationale for the importance of cathepsin D in breast cancer is a provocative one. Cathepsin D is both an estrogen inducible and a constitutively produced protease, which may also act directly as a peptide growth factor. Thus it may play a role in tumor invasiveness, and also in driving cell proliferation. Reported clinical studies are conflicting, with some studies showing cathepsin D levels to correlate with clinical outcome, and other studies finding prognostic significance only in selected subsets of patients, if any. Thus cathepsin D is a potentially important prognostic marker whose clinical application awaits further definition.Keywords
This publication has 17 references indexed in Scilit:
- Why do so many prognostic factors fail to pan out?Breast Cancer Research and Treatment, 1992
- Prognostic value of total cathepsin D in breast tumorsBreast Cancer Research and Treatment, 1991
- Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersEuropean Journal of Cancer and Clinical Oncology, 1991
- MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin DExperimental Cell Research, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancerJournal of Steroid Biochemistry, 1989
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cellsMolecular and Cellular Endocrinology, 1989
- The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic proteaseBiochemical and Biophysical Research Communications, 1986
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980